Literature DB >> 11247966

Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure.

E C Fletcher1.   

Abstract

One of the major manifestations of obstructive sleep apnea is profound and repeated hypoxia during sleep. Acute hypoxia leads to stimulation of the peripheral chemoreceptors, which in turn increases sympathetic outflow, acutely increasing blood pressure. The chronic effect of these repeated episodic or intermittent periods of hypoxia in humans is difficult to study because chronic cardiovascular changes may take many years to manifest. Rodents have been a tremendous source of information in short- and long-term studies of hypertension and other cardiovascular diseases. Recurrent short cycles of normoxia-hypoxia, when administered to rats for 35 days, allows examination of the chronic cardiovascular response to intermittent hypoxia patterned after the episodic desaturation seen in humans with sleep apnea. The result of this type of intermittent hypoxia in rats is a 10- to 14-mmHg increase in resting (unstimulated) mean blood pressure that lasts for several weeks after cessation of the daily cyclic hypoxia. Carotid body denervation, sympathetic nerve ablation, renal sympathectomy, adrenal medullectomy, and angiotensin II receptor blockade block the blood pressure increase. It appears that adrenergic and renin-angiotensin system overactivity contributes to the early chronic elevated blood pressure in rat intermittent hypoxia and perhaps to human hypertension associated with obstructive sleep apnea.

Entities:  

Mesh:

Year:  2001        PMID: 11247966     DOI: 10.1152/jappl.2001.90.4.1600

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  124 in total

1.  Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats.

Authors:  Xiao-Mei Xu; Dan Yao; Xue-Ding Cai; Cheng Ding; Qian-Ding Lin; Liang-Xing Wang; Xiao-Ying Huang
Journal:  Sleep Breath       Date:  2014-11-14       Impact factor: 2.816

2.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

Review 3.  Neurobiology and neuropathophysiology of obstructive sleep apnea.

Authors:  Yanpeng Li; Sigrid C Veasey
Journal:  Neuromolecular Med       Date:  2011-12-15       Impact factor: 3.843

Review 4.  Sympatho-adrenal activation by chronic intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar; Ying-Jie Peng
Journal:  J Appl Physiol (1985)       Date:  2012-06-21

5.  Disparities in obstructive sleep apnea and its management between a minority-serving institution and a voluntary hospital.

Authors:  Harly Greenberg; Jean Fleischman; Hossam E Gouda; Angel E De La Cruz; Ricardo Lopez; Karen Mrejen; Anna Web; Steven Feinsilver
Journal:  Sleep Breath       Date:  2004-12       Impact factor: 2.816

6.  Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity.

Authors:  Daniel B Zoccal; Annabel E Simms; Leni G H Bonagamba; Valdir A Braga; Anthony E Pickering; Julian F R Paton; Benedito H Machado
Journal:  J Physiol       Date:  2008-05-01       Impact factor: 5.182

Review 7.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

Review 8.  Sensing hypoxia: physiology, genetics and epigenetics.

Authors:  Nanduri R Prabhakar
Journal:  J Physiol       Date:  2013-03-04       Impact factor: 5.182

Review 9.  Rostral Ventrolateral Medulla and Hypertension.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

10.  Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans.

Authors:  Jose A L Calbet
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.